#USA #Arlington #ALS Research #ALS Association #ACT for ALS

A Major Step Forward for ALS

The ALS Association is thrilled to announce that the ACT for ALS Act has officially been signed into law by the President. This significant milestone represents years of dedication and advocacy within the ALS community, aimed at improving the lives of those affected by Amyotrophic Lateral Sclerosis (ALS).

The Importance of the ACT for ALS

Originally passed in 2021, the ACT for ALS paved the way for increased funding and support for ALS research and treatments. The recent reauthorization of this act ensures that vital research initiatives and access to treatment programs will continue through 2031. This is essential for accelerating the development of effective therapies and ultimately a cure for ALS.

Calaneet Balas, president and CEO of the ALS Association, emphasized the collective effort involved in achieving this legislative triumph. "This victory belongs to the entire ALS community," she stated, highlighting the collaboration between advocates, families, and bipartisan congressional champions. Together, they worked tirelessly to ensure the voices and needs of those living with ALS were at the forefront of the legislative process.

Mobilizing the ALS Community

The ALS Association played a pivotal role in mobilizing supporters in all 50 states, ensuring that Congressional leaders understood the urgent needs of the ALS community. Strong advocacy led to the bill being shaped around the priorities expressed by families affected by ALS. These priorities include reducing barriers to access, increasing research funding, and fostering accountability in how the funds are utilized to produce tangible results.

Families shared their challenging experiences to help illuminate the critical importance of research into promising ALS therapies. Their stories inspired action and underscored the fact that effective treatments cannot wait. As Balas remarked, the efforts by advocates to meet with lawmakers and share their personal struggles made a crucial difference in driving this legislation.

Looking Ahead: Continuing the Fight Against ALS

The reauthorization not only builds upon the framework established by the original ACT for ALS but also strengthens the focus on learning which treatments are effective and expediting their delivery to ALS patients. This comprehensive approach aligns with the ALS Association's commitment to expedite research and development of effective therapies while maintaining transparency and accountability throughout the process.

"We must accelerate research and technology to help make ALS livable and ultimately find a cure," Balas reiterated. The renewed support will sustain funding for ongoing research, provide critical resources to families, and continue advocating for necessary changes in public policy to prioritize ALS care and research.

About the ALS Association

The ALS Association stands as the foremost organization advocating for individuals with ALS globally. It focuses on funding extensive research collaborations, offering support to affected families through a national network of certified care centers, and campaigning for better public policies. The overarching goal is to transform ALS into a livable disease while pushing for innovative treatments and a definitive cure.

For more information about the ALS Association and the groundbreaking work being undertaken, visit their official website at www.als.org.

Understanding ALS

Amyotrophic Lateral Sclerosis, commonly known as ALS, is a relentless neurological disease that progressively affects nerve cells within the brain and spinal cord. As the disease advances, individuals experience loss of mobility, speech, and eventually, the capability to breathe, leading to a fatal outcome typically within five years of diagnosis. The limited treatment options available underscore the urgent need for new therapies to manage this devastating condition effectively.